Skip to content
AwardedGermanyGoods€1

Abschluss eines nicht-exklusiven Rabattvertrages gemäß §§ 130a Abs. 8 und 130c Abs. 1 SGB V zwischen der IKK classic und der GlaxoSmithKline GmbH & Co. KG zu Exdensur

Published
Published 1 April 2026

Overview

Abschluss eines nicht-exklusiven Rabattvertrages gemäß §§ 130a Abs. 8 und 130c Abs. 1 SGB V zwischen der IKK classic und der GlaxoSmithKline GmbH & Co. KG zu Exdensur (Wirkstoff: Depemokimab , ATC-Codes: R03DX12), Vertragslaufzeit: 01.04.2026-31.03.2028

Key details

Country
Germany
Status
Awarded
Category
Goods
Estimated value
€1
Procedure
Direct
Published
1 April 2026
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
€1
Award date
24 March 2026
Winner
  • GlaxoSmithKline GmbH & Co. KG

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    1 April 2026

Contracting authority

  • IKK classic

    Procuring entity

    Dresden, Germany

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Abschluss eines nicht-exklusiven Rabattvertrages gemäß §§ 130a Abs. 8 und 130c Abs. 1 SGB V zwischen der IKK classic und der GlaxoSmithKline GmbH & Co. KG zu Exdensur — won by GlaxoSmithKline GmbH & Co. KG — Skim